Company profile
Idun Pharmaceuticals company profile
IDUN Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of human therapeutics to control apoptosis. Its products under Phase 2 and preclinical trials include drugs for liver disease, CNS diseases, inflammation, and cancer, as well as IDN-6556 for the treatment of liver diseases in patients infected with Hepatitis C virus. The company was founded in 1993 and is based in San Diego, California. As of July 30, 2010, IDUN Pharmaceuticals, Inc. operates as a subsidiary of Conatus Pharmaceuticals Inc.
Business identity
- Website
- https://www.idun.com/sv/
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 501-1,000 employees
- Revenue range
- $1M-$10M
- Founded
- 1993-01-01, Year
Headquarters
- Headquarters
- Wonewoc, Wisconsin, United States
- Postal code
- 92128
- Country code
- US
- Continent
- North America